Repligen Corporation Common Stock (RGEN)
Repligen Corporation Common Stock (RGEN) has reported earnings 20 times since Jul 27, 2021. The stock moves an average of ±5.66% the day after reporting, closing higher 65.0% of the time. Its largest post-earnings gain was +18.12% (Oct 31, 2023) and its largest decline was -5.81% (Oct 28, 2025). The next earnings report is predicted for 2026-07-21 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
20
Avg Abs. Movement
±5.66%
Positive %
65.0%
Negative %
35.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 05, 2026 | ☀ PRE | $121.37 | $128.04 | $125.70 | 164,289 | +6.35% | open_in_new |
| Feb 24, 2026 | ☀ PRE | $121.12 | $139.44 | $134.55 | 168,032 | -0.85% | open_in_new |
| Oct 28, 2025 | ☀ PRE | $164.61 | $166.61 | $151.44 | 119,679 | -5.81% | open_in_new |
| Jul 29, 2025 | ☀ PRE | $125.00 | $131.99 | $125.51 | 151,181 | +4.85% | open_in_new |
| Apr 29, 2025 | ☀ PRE | $135.94 | $145.47 | $139.48 | 150,929 | -2.93% | open_in_new |
| Feb 20, 2025 | ☀ PRE | $159.50 | $167.25 | $162.76 | 182,449 | +7.93% | open_in_new |
| Nov 12, 2024 | ☀ PRE | $146.25 | $154.04 | $148.62 | 98,046 | +6.66% | open_in_new |
| Sep 18, 2024 | ☽ POST | $137.35 | $143.47 | $142.04 | 88,884 | +2.65% | open_in_new |
| May 01, 2024 | ☀ PRE | $162.06 | $163.18 | $158.31 | 47,463 | -3.66% | open_in_new |
| Feb 21, 2024 | ☀ PRE | $189.07 | $202.31 | $194.07 | 89,851 | -2.78% | open_in_new |
| Oct 31, 2023 | ☀ PRE | $134.50 | $141.44 | $134.48 | 122,125 | +18.12% | open_in_new |
| Aug 02, 2023 | ☀ PRE | $167.22 | $181.18 | $170.56 | 98,454 | +2.13% | open_in_new |
| May 02, 2023 | ☀ PRE | $157.16 | $162.28 | $157.22 | 138,068 | +2.43% | open_in_new |
| Feb 22, 2023 | ☀ PRE | $179.95 | $181.51 | $170.02 | 124,901 | -4.42% | open_in_new |
| Nov 01, 2022 | ☀ PRE | $168.27 | $188.18 | $185.75 | 136,191 | +1.81% | open_in_new |
| Aug 02, 2022 | ☀ PRE | $220.80 | $244.49 | $237.48 | 168,980 | +11.72% | open_in_new |
| Apr 27, 2022 | ☀ PRE | $146.50 | $171.16 | $157.41 | 162,826 | +10.54% | open_in_new |
| Feb 17, 2022 | ☀ PRE | $186.53 | $189.41 | $182.71 | 51,163 | -0.65% | open_in_new |
| Oct 28, 2021 | ☀ PRE | $271.33 | $290.99 | $289.99 | 49,308 | +7.04% | open_in_new |
| Jul 27, 2021 | ☀ PRE | $213.32 | $226.47 | $226.28 | 95,144 | +9.82% | open_in_new |
Earnings Count
20
Total earnings in dataset
Avg Abs. Movement
±5.66%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
9 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260518 | open_in_new SEC.gov |
| 4 | 20260518 | open_in_new SEC.gov |
| 4 | 20260518 | open_in_new SEC.gov |
| 4 | 20260518 | open_in_new SEC.gov |
| 4 | 20260518 | open_in_new SEC.gov |
| 4 | 20260518 | open_in_new SEC.gov |
| 4 | 20260518 | open_in_new SEC.gov |
| 4 | 20260518 | open_in_new SEC.gov |
| 8-K | 20260515 | open_in_new SEC.gov |
Frequently asked about RGEN earnings
When does Repligen Corporation Common Stock report earnings next? expand_more
Repligen Corporation Common Stock (RGEN)'s next earnings date is approximate for 2026-07-21. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does RGEN stock move after earnings? expand_more
Over 20 reports, RGEN has moved an average of ±5.66% the session after earnings, closing higher 65.0% of the time.
What was RGEN's biggest post-earnings move? expand_more
RGEN's largest post-earnings gain on record was +18.12% on Oct 31, 2023, and its largest decline was -5.81% on Oct 28, 2025.
Where can I find Repligen Corporation Common Stock's SEC filings? expand_more
All of Repligen Corporation Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right